Literature DB >> 28619152

The newly emerging duck-origin goose parvovirus in China exhibits a wide range of pathogenicity to main domesticated waterfowl.

Shifeng Xiao1, Shilong Chen1, Xiaoxia Cheng1, Fengqiang Lin1, Shao Wang1, Xiaoli Zhu1, Bo Yu2, Meiqing Huang1, Jinxiang Wang1, Nanyang Wu1, Min Zheng1, Shaoying Chen3, Fusong Yu4.   

Abstract

Short beak and dwarfism syndrome virus (SBDSV) is a newly emerging distinct duck-origin goose parvovirus that belongs to the genus Dependovirus. Our previous studies have found that SBDSV was highly pathogenic to Cherry Valley ducklings and mule ducklings. However, little is known about its pathogenicity to other waterfowls. In the present study, the pathogenicity of SBDSV was evaluated in domesticated waterfowl including Muscovy ducklings, Sheldrake ducklings and domestic goslings. All experimentally infected birds exhibited remarkable growth retardation, anorexia and diarrhea similar to naturally infected birds. Interestingly, atrophic beaks and protruded tongues were not observed in all infection groups. At necropsies, no diagnostic pathological lesions were observed. Viral antigens existed in most organ tissues such as heart, liver, spleen, kidney, pancreas and intestine. All ducks in Muscovy duckling and Sheldrake duckling infected groups and 70% goslings in infected groups were seropositive for goose parvovirus (GPV) antibodies at 21dpi with the average titers as 28.4, 26.9, 24.0, respectively. Muscovy ducklings were more prominent in viral load and weight loss with a higher GPV antibodies titer than Sheldrake ducklings and goslings. Taken together, SBDSV exhibits a wide range of pathogenicity to main domesticated waterfowl with variable symptoms and cause considerable economic losses in China.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Distinct duck-origin goose parvovirus; Goslings; Muscovy ducklings; Pathogenicity; Sheldrake ducklings; Short beak and dwarfism syndrome

Mesh:

Year:  2017        PMID: 28619152     DOI: 10.1016/j.vetmic.2017.03.012

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Immunogenicity of an inactivated novel goose parvovirus vaccine for short beak and dwarfism syndrome in Cherry Valley ducks.

Authors:  Jiewen Zhou; Chuanfeng Li; Aoxing Tang; Hang Li; Zhaorong Yu; Zongyan Chen; Xin Guo; Guangqing Liu
Journal:  Arch Virol       Date:  2022-02-11       Impact factor: 2.574

2.  Development and application of a multiplex PCR method for simultaneous detection of waterfowl parvovirus, duck enteritis virus and goose astrovirus.

Authors:  Yin Dai; Meizhen Li; Xiaomiao Hu; Ruihong Zhao; Lunzhi Xia
Journal:  3 Biotech       Date:  2022-08-03       Impact factor: 2.893

3.  Effect of Goose Parvovirus and Duck Circovirus Coinfection in Ducks.

Authors:  Jie Liu; Xiaoxia Yang; Xiaojing Hao; Yongsheng Feng; Yuli Zhang; Ziqiang Cheng
Journal:  J Vet Res       Date:  2020-07-14       Impact factor: 1.744

4.  Rapid detection of H146-like goose calicivirus using a TaqMan-based real-time PCR assay.

Authors:  Min Zheng; Su Lin; Shizhong Zhang; Xiuqin Chen; Dandan Jiang; Shaoying Chen; Shao Wang; Shilong Chen
Journal:  Poult Sci       Date:  2020-11-19       Impact factor: 3.352

5.  Recombinant Muscovy Duck Parvovirus Led to Ileac Damage in Muscovy Ducklings.

Authors:  Jiahui He; Yukun Zhang; Zezhong Hu; Luxuan Zhang; Guanming Shao; Zi Xie; Yu Nie; Wenxue Li; Yajuan Li; Liyi Chen; Benli Huang; Fengsheng Chu; Keyu Feng; Wencheng Lin; Hongxin Li; Weiguo Chen; Xinheng Zhang; Qingmei Xie
Journal:  Viruses       Date:  2022-07-03       Impact factor: 5.818

6.  Development and Evaluation of NanoPCR for the Detection of Goose Parvovirus.

Authors:  Haoyuan Ma; Xu Gao; Jingfeng Fu; Haowen Xue; Yanhao Song; Kunru Zhu
Journal:  Vet Sci       Date:  2022-08-27

7.  Advances in Research on Genetic Relationships of Waterfowl Parvoviruses.

Authors:  Yanhui Chen; Ruth Afumba; Fusheng Pang; Rongxin Yuan; Hao Dong
Journal:  J Vet Res       Date:  2021-12-02       Impact factor: 1.744

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.